SEC Says FDA Chemist Made $3.6M In Insider Trading

Law360, New York (March 29, 2011, 7:32 PM EDT) -- The U.S. Securities and Exchange Commission accused a Food and Drug Administration chemist in Maryland federal court on Tuesday of using internal information about upcoming drug approval decisions to make trades worth more than $3.6 million.

The SEC said in a U.S. District Court for the District of Maryland complaint that Cheng Yi Liang, who works at the FDA's Center for Drug Evaluation and Research, regularly looked up information about a drug's pending application and then traded in the drug company's securities prior to any public...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.